Feder M, Finan J, Besa E, Nowell P
Cancer Genet Cytogenet. 1985 Feb 1;15(1-2):143-50. doi: 10.1016/0165-4608(85)90142-6.
Three patients with dysmyelopoietic preleukemia had a marrow clone with translocation t(2;11)(p21;q23) as the only chromosome change. In one patient, the cytogenetically altered cells disappeared following treatment with 13-cis-retinoic acid. Although these patients did not constitute a homogeneous clinical subgroup, the 2p;11q translocation should probably be added to the short list of nonrandom karyotypic alterations involving 11q23 that have been described in various hematopoietic disorders.
三名骨髓生成异常的白血病前期患者有一个骨髓克隆,其唯一的染色体改变为t(2;11)(p21;q23)易位。在一名患者中,经13-顺式维甲酸治疗后,细胞遗传学改变的细胞消失。尽管这些患者并不构成一个同质的临床亚组,但2p;11q易位可能应被添加到涉及11q23的非随机核型改变的简短列表中,这些改变已在各种造血系统疾病中有所描述。